Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

The Next Web
Read the full article
Reid Hoffman has resigned from Microsoft's board to focus on leading Manus, an AI-driven drug discovery startup. This move marks his shift towards entrepreneurship in the AI healthcare sector.

More in Healthcare

Your Selfie Could Become A Medical Metric: Mass General Brigham’s AI Face-Scanning Breakthrough

Forbes
Healthcare3 min read

scBOA: Bayesian optimization of single-cell analysis pipelines for robust annotation and discovery

Nature

UnitedHealthcare Is Rolling Out Its AI Agent To 21 Million Members

Forbes